The global market for Small Molecule Drug CDMO was estimated to be worth US$ 27840 million in 2023 and is forecast to a readjusted size of US$ 41580 million by 2030 with a CAGR of 5.9% during the forecast period 2024-2030

Small Molecule Drug CDMO - Market

A CDMO is a company dedicated to providing drug development and manufacturing services for the pharmaceutical and biotechnology industries. CDMO activities can broadly be divided into four fields: product development, manufacture of active pharmaceutical ingredients (API), manufacture of finished dosage forms (FDF) and pharma packaging.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Small Molecule Drug CDMO, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Small Molecule Drug CDMO by region & country, by Type, and by Application.

The Small Molecule Drug CDMO market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Molecule Drug CDMO.

Market Segmentation

Scope of Small Molecule Drug CDMO - Market Report

Report Metric	Details
Report Name	Small Molecule Drug CDMO - Market
Forecasted market size in 2030	US$ 41580 million
CAGR	5.9%
Forecasted years	2024 - 2030
Segment by Type:	FDF CDMO Packaging CDMO Clinical CDMO
Segment by Application	Pharmaceutical Company Biotechnology Company Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Lonza, Catalent, Thermo Fisher Scientific, Samsung Biologics, Fareva, WuXi AppTech, WuXi Biologics, Siegfried, FUJIFILM Diosynth Biotechnologies, Asymchem, Pfizer CentreOne, Delpharm, Recipharm, AGC Pharma Chemicals, Boehringer Ingelheim, Vetter, Curia, Aenova, Porton
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Small Molecule Drug CDMO manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Small Molecule Drug CDMO in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Small Molecule Drug CDMO in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Small Molecule Drug CDMO - Market size in 2030?

Ans: The Small Molecule Drug CDMO - Market size in 2030 will be US$ 41580 million.

Who are the main players in the Small Molecule Drug CDMO - Market report?

Ans: The main players in the Small Molecule Drug CDMO - Market are Lonza, Catalent, Thermo Fisher Scientific, Samsung Biologics, Fareva, WuXi AppTech, WuXi Biologics, Siegfried, FUJIFILM Diosynth Biotechnologies, Asymchem, Pfizer CentreOne, Delpharm, Recipharm, AGC Pharma Chemicals, Boehringer Ingelheim, Vetter, Curia, Aenova, Porton

What are the Application segmentation covered in the Small Molecule Drug CDMO - Market report?

Ans: The Applications covered in the Small Molecule Drug CDMO - Market report are Pharmaceutical Company, Biotechnology Company, Other

What are the Type segmentation covered in the Small Molecule Drug CDMO - Market report?

Ans: The Types covered in the Small Molecule Drug CDMO - Market report are FDF CDMO, Packaging CDMO, Clinical CDMO

1 Market Overview

1.1 Small Molecule Drug CDMO Product Introduction

1.2 Global Small Molecule Drug CDMO Market Size Forecast

1.3 Small Molecule Drug CDMO Market Trends & Drivers

1.3.1 Small Molecule Drug CDMO Industry Trends

1.3.2 Small Molecule Drug CDMO Market Drivers & Opportunity

1.3.3 Small Molecule Drug CDMO Market Challenges

1.3.4 Small Molecule Drug CDMO Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Small Molecule Drug CDMO Players Revenue Ranking (2023)

2.2 Global Small Molecule Drug CDMO Revenue by Company (2019-2024)

2.3 Key Companies Small Molecule Drug CDMO Manufacturing Base Distribution and Headquarters

2.4 Key Companies Small Molecule Drug CDMO Product Offered

2.5 Key Companies Time to Begin Mass Production of Small Molecule Drug CDMO

2.6 Small Molecule Drug CDMO Market Competitive Analysis

2.6.1 Small Molecule Drug CDMO Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Small Molecule Drug CDMO Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Drug CDMO as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 FDF CDMO

3.1.2 Packaging CDMO

3.1.3 Clinical CDMO

3.2 Global Small Molecule Drug CDMO Sales Value by Type

3.2.1 Global Small Molecule Drug CDMO Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Small Molecule Drug CDMO Sales Value, by Type (2019-2030)

3.2.3 Global Small Molecule Drug CDMO Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Pharmaceutical Company

4.1.2 Biotechnology Company

4.1.3 Other

4.2 Global Small Molecule Drug CDMO Sales Value by Application

4.2.1 Global Small Molecule Drug CDMO Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Small Molecule Drug CDMO Sales Value, by Application (2019-2030)

4.2.3 Global Small Molecule Drug CDMO Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Small Molecule Drug CDMO Sales Value by Region

5.1.1 Global Small Molecule Drug CDMO Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Small Molecule Drug CDMO Sales Value by Region (2019-2024)

5.1.3 Global Small Molecule Drug CDMO Sales Value by Region (2025-2030)

5.1.4 Global Small Molecule Drug CDMO Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Small Molecule Drug CDMO Sales Value, 2019-2030

5.2.2 North America Small Molecule Drug CDMO Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Small Molecule Drug CDMO Sales Value, 2019-2030

5.3.2 Europe Small Molecule Drug CDMO Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Small Molecule Drug CDMO Sales Value, 2019-2030

5.4.2 Asia Pacific Small Molecule Drug CDMO Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Small Molecule Drug CDMO Sales Value, 2019-2030

5.5.2 South America Small Molecule Drug CDMO Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Small Molecule Drug CDMO Sales Value, 2019-2030

5.6.2 Middle East & Africa Small Molecule Drug CDMO Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Small Molecule Drug CDMO Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Small Molecule Drug CDMO Sales Value

6.3 United States

6.3.1 United States Small Molecule Drug CDMO Sales Value, 2019-2030

6.3.2 United States Small Molecule Drug CDMO Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Small Molecule Drug CDMO Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Small Molecule Drug CDMO Sales Value, 2019-2030

6.4.2 Europe Small Molecule Drug CDMO Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Small Molecule Drug CDMO Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Small Molecule Drug CDMO Sales Value, 2019-2030

6.5.2 China Small Molecule Drug CDMO Sales Value by Type (%), 2023 VS 2030

6.5.3 China Small Molecule Drug CDMO Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Small Molecule Drug CDMO Sales Value, 2019-2030

6.6.2 Japan Small Molecule Drug CDMO Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Small Molecule Drug CDMO Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Small Molecule Drug CDMO Sales Value, 2019-2030

6.7.2 South Korea Small Molecule Drug CDMO Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Small Molecule Drug CDMO Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Small Molecule Drug CDMO Sales Value, 2019-2030

6.8.2 Southeast Asia Small Molecule Drug CDMO Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Small Molecule Drug CDMO Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Small Molecule Drug CDMO Sales Value, 2019-2030

6.9.2 India Small Molecule Drug CDMO Sales Value by Type (%), 2023 VS 2030

6.9.3 India Small Molecule Drug CDMO Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Lonza

7.1.1 Lonza Profile

7.1.2 Lonza Main Business

7.1.3 Lonza Small Molecule Drug CDMO Products, Services and Solutions

7.1.4 Lonza Small Molecule Drug CDMO Revenue (US$ Million) & (2019-2024)

7.1.5 Lonza Recent Developments

7.2 Catalent

7.2.1 Catalent Profile

7.2.2 Catalent Main Business

7.2.3 Catalent Small Molecule Drug CDMO Products, Services and Solutions

7.2.4 Catalent Small Molecule Drug CDMO Revenue (US$ Million) & (2019-2024)

7.2.5 Catalent Recent Developments

7.3 Thermo Fisher Scientific

7.3.1 Thermo Fisher Scientific Profile

7.3.2 Thermo Fisher Scientific Main Business

7.3.3 Thermo Fisher Scientific Small Molecule Drug CDMO Products, Services and Solutions

7.3.4 Thermo Fisher Scientific Small Molecule Drug CDMO Revenue (US$ Million) & (2019-2024)

7.3.5 Samsung Biologics Recent Developments

7.4 Samsung Biologics

7.4.1 Samsung Biologics Profile

7.4.2 Samsung Biologics Main Business

7.4.3 Samsung Biologics Small Molecule Drug CDMO Products, Services and Solutions

7.4.4 Samsung Biologics Small Molecule Drug CDMO Revenue (US$ Million) & (2019-2024)

7.4.5 Samsung Biologics Recent Developments

7.5 Fareva

7.5.1 Fareva Profile

7.5.2 Fareva Main Business

7.5.3 Fareva Small Molecule Drug CDMO Products, Services and Solutions

7.5.4 Fareva Small Molecule Drug CDMO Revenue (US$ Million) & (2019-2024)

7.5.5 Fareva Recent Developments

7.6 WuXi AppTech

7.6.1 WuXi AppTech Profile

7.6.2 WuXi AppTech Main Business

7.6.3 WuXi AppTech Small Molecule Drug CDMO Products, Services and Solutions

7.6.4 WuXi AppTech Small Molecule Drug CDMO Revenue (US$ Million) & (2019-2024)

7.6.5 WuXi AppTech Recent Developments

7.7 WuXi Biologics

7.7.1 WuXi Biologics Profile

7.7.2 WuXi Biologics Main Business

7.7.3 WuXi Biologics Small Molecule Drug CDMO Products, Services and Solutions

7.7.4 WuXi Biologics Small Molecule Drug CDMO Revenue (US$ Million) & (2019-2024)

7.7.5 WuXi Biologics Recent Developments

7.8 Siegfried

7.8.1 Siegfried Profile

7.8.2 Siegfried Main Business

7.8.3 Siegfried Small Molecule Drug CDMO Products, Services and Solutions

7.8.4 Siegfried Small Molecule Drug CDMO Revenue (US$ Million) & (2019-2024)

7.8.5 Siegfried Recent Developments

7.9 FUJIFILM Diosynth Biotechnologies

7.9.1 FUJIFILM Diosynth Biotechnologies Profile

7.9.2 FUJIFILM Diosynth Biotechnologies Main Business

7.9.3 FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Products, Services and Solutions

7.9.4 FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Revenue (US$ Million) & (2019-2024)

7.9.5 FUJIFILM Diosynth Biotechnologies Recent Developments

7.10 Asymchem

7.10.1 Asymchem Profile

7.10.2 Asymchem Main Business

7.10.3 Asymchem Small Molecule Drug CDMO Products, Services and Solutions

7.10.4 Asymchem Small Molecule Drug CDMO Revenue (US$ Million) & (2019-2024)

7.10.5 Asymchem Recent Developments

7.11 Pfizer CentreOne

7.11.1 Pfizer CentreOne Profile

7.11.2 Pfizer CentreOne Main Business

7.11.3 Pfizer CentreOne Small Molecule Drug CDMO Products, Services and Solutions

7.11.4 Pfizer CentreOne Small Molecule Drug CDMO Revenue (US$ Million) & (2019-2024)

7.11.5 Pfizer CentreOne Recent Developments

7.12 Delpharm

7.12.1 Delpharm Profile

7.12.2 Delpharm Main Business

7.12.3 Delpharm Small Molecule Drug CDMO Products, Services and Solutions

7.12.4 Delpharm Small Molecule Drug CDMO Revenue (US$ Million) & (2019-2024)

7.12.5 Delpharm Recent Developments

7.13 Recipharm

7.13.1 Recipharm Profile

7.13.2 Recipharm Main Business

7.13.3 Recipharm Small Molecule Drug CDMO Products, Services and Solutions

7.13.4 Recipharm Small Molecule Drug CDMO Revenue (US$ Million) & (2019-2024)

7.13.5 Recipharm Recent Developments

7.14 AGC Pharma Chemicals

7.14.1 AGC Pharma Chemicals Profile

7.14.2 AGC Pharma Chemicals Main Business

7.14.3 AGC Pharma Chemicals Small Molecule Drug CDMO Products, Services and Solutions

7.14.4 AGC Pharma Chemicals Small Molecule Drug CDMO Revenue (US$ Million) & (2019-2024)

7.14.5 AGC Pharma Chemicals Recent Developments

7.15 Boehringer Ingelheim

7.15.1 Boehringer Ingelheim Profile

7.15.2 Boehringer Ingelheim Main Business

7.15.3 Boehringer Ingelheim Small Molecule Drug CDMO Products, Services and Solutions

7.15.4 Boehringer Ingelheim Small Molecule Drug CDMO Revenue (US$ Million) & (2019-2024)

7.15.5 Boehringer Ingelheim Recent Developments

7.16 Vetter

7.16.1 Vetter Profile

7.16.2 Vetter Main Business

7.16.3 Vetter Small Molecule Drug CDMO Products, Services and Solutions

7.16.4 Vetter Small Molecule Drug CDMO Revenue (US$ Million) & (2019-2024)

7.16.5 Vetter Recent Developments

7.17 Curia

7.17.1 Curia Profile

7.17.2 Curia Main Business

7.17.3 Curia Small Molecule Drug CDMO Products, Services and Solutions

7.17.4 Curia Small Molecule Drug CDMO Revenue (US$ Million) & (2019-2024)

7.17.5 Curia Recent Developments

7.18 Aenova

7.18.1 Aenova Profile

7.18.2 Aenova Main Business

7.18.3 Aenova Small Molecule Drug CDMO Products, Services and Solutions

7.18.4 Aenova Small Molecule Drug CDMO Revenue (US$ Million) & (2019-2024)

7.18.5 Aenova Recent Developments

7.19 Porton

7.19.1 Porton Profile

7.19.2 Porton Main Business

7.19.3 Porton Small Molecule Drug CDMO Products, Services and Solutions

7.19.4 Porton Small Molecule Drug CDMO Revenue (US$ Million) & (2019-2024)

7.19.5 Porton Recent Developments

8 Industry Chain Analysis

8.1 Small Molecule Drug CDMO Industrial Chain

8.2 Small Molecule Drug CDMO Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Small Molecule Drug CDMO Sales Model

8.5.2 Sales Channel

8.5.3 Small Molecule Drug CDMO Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Lonza

Catalent

Thermo Fisher Scientific

FUJIFILM Diosynth Biotechnologies

List of Tables

Table 1. Small Molecule Drug CDMO Market Trends

Table 2. Small Molecule Drug CDMO Market Drivers & Opportunity

Table 3. Small Molecule Drug CDMO Market Challenges

Table 4. Small Molecule Drug CDMO Market Restraints

Table 5. Global Small Molecule Drug CDMO Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Small Molecule Drug CDMO Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Small Molecule Drug CDMO Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Small Molecule Drug CDMO Product Type

Table 9. Key Companies Time to Begin Mass Production of Small Molecule Drug CDMO

Table 10. Global Small Molecule Drug CDMO Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Drug CDMO as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Small Molecule Drug CDMO Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Small Molecule Drug CDMO Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Small Molecule Drug CDMO Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Small Molecule Drug CDMO Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Small Molecule Drug CDMO Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Small Molecule Drug CDMO Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Small Molecule Drug CDMO Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Small Molecule Drug CDMO Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Small Molecule Drug CDMO Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Small Molecule Drug CDMO Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Small Molecule Drug CDMO Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Small Molecule Drug CDMO Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Small Molecule Drug CDMO Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Small Molecule Drug CDMO Sales Value by Region (2019-2024) & (%)

Table 27. Global Small Molecule Drug CDMO Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Small Molecule Drug CDMO Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Small Molecule Drug CDMO Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Small Molecule Drug CDMO Sales Value, (2025-2030) & (US$ Million)

Table 31. Lonza Basic Information List

Table 32. Lonza Description and Business Overview

Table 33. Lonza Small Molecule Drug CDMO Products, Services and Solutions

Table 34. Revenue (US$ Million) in Small Molecule Drug CDMO Business of Lonza (2019-2024)

Table 35. Lonza Recent Developments

Table 36. Catalent Basic Information List

Table 37. Catalent Description and Business Overview

Table 38. Catalent Small Molecule Drug CDMO Products, Services and Solutions

Table 39. Revenue (US$ Million) in Small Molecule Drug CDMO Business of Catalent (2019-2024)

Table 40. Catalent Recent Developments

Table 41. Thermo Fisher Scientific Basic Information List

Table 42. Thermo Fisher Scientific Description and Business Overview

Table 43. Thermo Fisher Scientific Small Molecule Drug CDMO Products, Services and Solutions

Table 44. Revenue (US$ Million) in Small Molecule Drug CDMO Business of Thermo Fisher Scientific (2019-2024)

Table 45. Thermo Fisher Scientific Recent Developments

Table 46. Samsung Biologics Basic Information List

Table 47. Samsung Biologics Description and Business Overview

Table 48. Samsung Biologics Small Molecule Drug CDMO Products, Services and Solutions

Table 49. Revenue (US$ Million) in Small Molecule Drug CDMO Business of Samsung Biologics (2019-2024)

Table 50. Samsung Biologics Recent Developments

Table 51. Fareva Basic Information List

Table 52. Fareva Description and Business Overview

Table 53. Fareva Small Molecule Drug CDMO Products, Services and Solutions

Table 54. Revenue (US$ Million) in Small Molecule Drug CDMO Business of Fareva (2019-2024)

Table 55. Fareva Recent Developments

Table 56. WuXi AppTech Basic Information List

Table 57. WuXi AppTech Description and Business Overview

Table 58. WuXi AppTech Small Molecule Drug CDMO Products, Services and Solutions

Table 59. Revenue (US$ Million) in Small Molecule Drug CDMO Business of WuXi AppTech (2019-2024)

Table 60. WuXi AppTech Recent Developments

Table 61. WuXi Biologics Basic Information List

Table 62. WuXi Biologics Description and Business Overview

Table 63. WuXi Biologics Small Molecule Drug CDMO Products, Services and Solutions

Table 64. Revenue (US$ Million) in Small Molecule Drug CDMO Business of WuXi Biologics (2019-2024)

Table 65. WuXi Biologics Recent Developments

Table 66. Siegfried Basic Information List

Table 67. Siegfried Description and Business Overview

Table 68. Siegfried Small Molecule Drug CDMO Products, Services and Solutions

Table 69. Revenue (US$ Million) in Small Molecule Drug CDMO Business of Siegfried (2019-2024)

Table 70. Siegfried Recent Developments

Table 71. FUJIFILM Diosynth Biotechnologies Basic Information List

Table 72. FUJIFILM Diosynth Biotechnologies Description and Business Overview

Table 73. FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Products, Services and Solutions

Table 74. Revenue (US$ Million) in Small Molecule Drug CDMO Business of FUJIFILM Diosynth Biotechnologies (2019-2024)

Table 75. FUJIFILM Diosynth Biotechnologies Recent Developments

Table 76. Asymchem Basic Information List

Table 77. Asymchem Description and Business Overview

Table 78. Asymchem Small Molecule Drug CDMO Products, Services and Solutions

Table 79. Revenue (US$ Million) in Small Molecule Drug CDMO Business of Asymchem (2019-2024)

Table 80. Asymchem Recent Developments

Table 81. Pfizer CentreOne Basic Information List

Table 82. Pfizer CentreOne Description and Business Overview

Table 83. Pfizer CentreOne Small Molecule Drug CDMO Products, Services and Solutions

Table 84. Revenue (US$ Million) in Small Molecule Drug CDMO Business of Pfizer CentreOne (2019-2024)

Table 85. Pfizer CentreOne Recent Developments

Table 86. Delpharm Basic Information List

Table 87. Delpharm Description and Business Overview

Table 88. Delpharm Small Molecule Drug CDMO Products, Services and Solutions

Table 89. Revenue (US$ Million) in Small Molecule Drug CDMO Business of Delpharm (2019-2024)

Table 90. Delpharm Recent Developments

Table 91. Recipharm Basic Information List

Table 92. Recipharm Description and Business Overview

Table 93. Recipharm Small Molecule Drug CDMO Products, Services and Solutions

Table 94. Revenue (US$ Million) in Small Molecule Drug CDMO Business of Recipharm (2019-2024)

Table 95. Recipharm Recent Developments

Table 96. AGC Pharma Chemicals Basic Information List

Table 97. AGC Pharma Chemicals Description and Business Overview

Table 98. AGC Pharma Chemicals Small Molecule Drug CDMO Products, Services and Solutions

Table 99. Revenue (US$ Million) in Small Molecule Drug CDMO Business of AGC Pharma Chemicals (2019-2024)

Table 100. AGC Pharma Chemicals Recent Developments

Table 101. Boehringer Ingelheim Basic Information List

Table 102. Boehringer Ingelheim Description and Business Overview

Table 103. Boehringer Ingelheim Small Molecule Drug CDMO Products, Services and Solutions

Table 104. Revenue (US$ Million) in Small Molecule Drug CDMO Business of Boehringer Ingelheim (2019-2024)

Table 105. Boehringer Ingelheim Recent Developments

Table 106. Vetter Basic Information List

Table 107. Vetter Description and Business Overview

Table 108. Vetter Small Molecule Drug CDMO Products, Services and Solutions

Table 109. Revenue (US$ Million) in Small Molecule Drug CDMO Business of Vetter (2019-2024)

Table 110. Vetter Recent Developments

Table 111. Curia Basic Information List

Table 112. Curia Description and Business Overview

Table 113. Curia Small Molecule Drug CDMO Products, Services and Solutions

Table 114. Revenue (US$ Million) in Small Molecule Drug CDMO Business of Curia (2019-2024)

Table 115. Curia Recent Developments

Table 116. Aenova Basic Information List

Table 117. Aenova Description and Business Overview

Table 118. Aenova Small Molecule Drug CDMO Products, Services and Solutions

Table 119. Revenue (US$ Million) in Small Molecule Drug CDMO Business of Aenova (2019-2024)

Table 120. Aenova Recent Developments

Table 121. Porton Basic Information List

Table 122. Porton Description and Business Overview

Table 123. Porton Small Molecule Drug CDMO Products, Services and Solutions

Table 124. Revenue (US$ Million) in Small Molecule Drug CDMO Business of Porton (2019-2024)

Table 125. Porton Recent Developments

Table 126. Key Raw Materials Lists

Table 127. Raw Materials Key Suppliers Lists

Table 128. Small Molecule Drug CDMO Downstream Customers

Table 129. Small Molecule Drug CDMO Distributors List

Table 130. Research Programs/Design for This Report

Table 131. Key Data Information from Secondary Sources

Table 132. Key Data Information from Primary Sources

Table 133. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Small Molecule Drug CDMO Product Picture

Figure 2. Global Small Molecule Drug CDMO Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Small Molecule Drug CDMO Sales Value (2019-2030) & (US$ Million)

Figure 4. Small Molecule Drug CDMO Report Years Considered

Figure 5. Global Small Molecule Drug CDMO Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Small Molecule Drug CDMO Revenue in 2023

Figure 7. Small Molecule Drug CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. FDF CDMO Picture

Figure 9. Packaging CDMO Picture

Figure 10. Clinical CDMO Picture

Figure 11. Global Small Molecule Drug CDMO Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 12. Global Small Molecule Drug CDMO Sales Value Market Share by Type, 2023 & 2030

Figure 13. Product Picture of Pharmaceutical Company

Figure 14. Product Picture of Biotechnology Company

Figure 15. Product Picture of Other

Figure 16. Global Small Molecule Drug CDMO Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 17. Global Small Molecule Drug CDMO Sales Value Market Share by Application, 2023 & 2030

Figure 18. North America Small Molecule Drug CDMO Sales Value (2019-2030) & (US$ Million)

Figure 19. North America Small Molecule Drug CDMO Sales Value by Country (%), 2023 VS 2030

Figure 20. Europe Small Molecule Drug CDMO Sales Value (2019-2030) & (US$ Million)

Figure 21. Europe Small Molecule Drug CDMO Sales Value by Country (%), 2023 VS 2030

Figure 22. Asia Pacific Small Molecule Drug CDMO Sales Value (2019-2030) & (US$ Million)

Figure 23. Asia Pacific Small Molecule Drug CDMO Sales Value by Country (%), 2023 VS 2030

Figure 24. South America Small Molecule Drug CDMO Sales Value (2019-2030) & (US$ Million)

Figure 25. South America Small Molecule Drug CDMO Sales Value by Country (%), 2023 VS 2030

Figure 26. Middle East & Africa Small Molecule Drug CDMO Sales Value (2019-2030) & (US$ Million)

Figure 27. Middle East & Africa Small Molecule Drug CDMO Sales Value by Country (%), 2023 VS 2030

Figure 28. Key Countries/Regions Small Molecule Drug CDMO Sales Value (%), (2019-2030)

Figure 29. United States Small Molecule Drug CDMO Sales Value, (2019-2030) & (US$ Million)

Figure 30. United States Small Molecule Drug CDMO Sales Value by Type (%), 2023 VS 2030

Figure 31. United States Small Molecule Drug CDMO Sales Value by Application (%), 2023 VS 2030

Figure 32. Europe Small Molecule Drug CDMO Sales Value, (2019-2030) & (US$ Million)

Figure 33. Europe Small Molecule Drug CDMO Sales Value by Type (%), 2023 VS 2030

Figure 34. Europe Small Molecule Drug CDMO Sales Value by Application (%), 2023 VS 2030

Figure 35. China Small Molecule Drug CDMO Sales Value, (2019-2030) & (US$ Million)

Figure 36. China Small Molecule Drug CDMO Sales Value by Type (%), 2023 VS 2030

Figure 37. China Small Molecule Drug CDMO Sales Value by Application (%), 2023 VS 2030

Figure 38. Japan Small Molecule Drug CDMO Sales Value, (2019-2030) & (US$ Million)

Figure 39. Japan Small Molecule Drug CDMO Sales Value by Type (%), 2023 VS 2030

Figure 40. Japan Small Molecule Drug CDMO Sales Value by Application (%), 2023 VS 2030

Figure 41. South Korea Small Molecule Drug CDMO Sales Value, (2019-2030) & (US$ Million)

Figure 42. South Korea Small Molecule Drug CDMO Sales Value by Type (%), 2023 VS 2030

Figure 43. South Korea Small Molecule Drug CDMO Sales Value by Application (%), 2023 VS 2030

Figure 44. Southeast Asia Small Molecule Drug CDMO Sales Value, (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Small Molecule Drug CDMO Sales Value by Type (%), 2023 VS 2030

Figure 46. Southeast Asia Small Molecule Drug CDMO Sales Value by Application (%), 2023 VS 2030

Figure 47. India Small Molecule Drug CDMO Sales Value, (2019-2030) & (US$ Million)

Figure 48. India Small Molecule Drug CDMO Sales Value by Type (%), 2023 VS 2030

Figure 49. India Small Molecule Drug CDMO Sales Value by Application (%), 2023 VS 2030

Figure 50. Small Molecule Drug CDMO Industrial Chain

Figure 51. Small Molecule Drug CDMO Manufacturing Cost Structure

Figure 52. Channels of Distribution (Direct Sales, and Distribution)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions